TickerFactsScreenerDevelopers

Kura Oncology, Inc. (KURA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2010: -$19.2K2011: -$22.7K2012: -$24.4K2013: -$23.2K2017: -$28.44M2018: -$48.66M2019: -$54.76M2020: -$69.83M2021: -$104.55M2022: -$110.06M2023: -$124.82M2024: $134.32M2025: -$64.06M-$64.06M
2010Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$64.06M-147.7%
2024$134.32M+207.6%
2023-$124.82M-13.4%
2022-$110.06M-5.3%
2021-$104.55M-49.7%
2020-$69.83M-27.5%
2019-$54.76M-12.5%
2018-$48.66M-71.1%
2017-$28.44M—
2013-$23.2K+4.8%
2012-$24.4K-7.7%
2011-$22.7K-17.8%
2010-$19.2K—